GSTO2 Inhibitors

GSTO2 inhibitors belong to a class of chemical compounds that specifically target and modulate the activity of Glutathione S-Transferase Omega 2 (GSTO2), an enzyme belonging to the glutathione S-transferase family. GSTO2 plays a crucial role in cellular detoxification processes by catalyzing the conjugation of reduced glutathione to a wide range of electrophilic substrates, facilitating their elimination from the cell. The inhibition of GSTO2 activity has garnered significant attention due to its potential implications in various physiological and pathological processes. These inhibitors typically interact with the active site of GSTO2, disrupting its catalytic function and interfering with the detoxification mechanisms mediated by this enzyme.

The development and study of GSTO2 inhibitors are rooted in the understanding that aberrant GSTO2 activity may contribute to cellular dysfunction and disease progression. By selectively inhibiting GSTO2, researchers aim to unravel the intricate biochemical pathways in which this enzyme participates, shedding light on its role in maintaining cellular homeostasis. The structural diversity of GSTO2 inhibitors allows for the exploration of structure-activity relationships, providing valuable insights into the key molecular determinants governing the interaction between these inhibitors and the enzyme.